We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Highlights A retrospective analysis of real-world data published in the ‘International Wound Journal’ compared the wound closure times for diabetic foot ulcers treated with either Endoform™...
HIGHLIGHTS Soft tissue regeneration company Aroa Biosurgery Limited has this week launched a new product named Myriad Morcells™, a morcellized (powder) format of Myriad Matrix™ that easily...
HIGHLIGHTS Further validation for Aroa’s Myriad™ from two clinical studies and peer-reviewed publications in Journal of Wound Care. One study shows high success rates, from use of Myriad™ in...
HIGHLIGHTS Further validation gained for Aroa’s proprietary Endoform® platform with peer-reviewed publication in PLOS ONE. Study provides further insights on the ability of components found...
HIGHLIGHTS Aroa lists on the ASX today after raising $45m at $0.75/share with an indicative market capitalisation of A$225m under the code ARX The Company has a range of five products that have...
RNS Number:6578U AeroBox plc 27 January 2004 27 January, 2004 Contact: Jeremy Porter, Seymour Pierce +44 20 7107 8000 David Bick, Holborn +44 20 7929 5599 Aerobox plc Further...
RNS Number:6107U AeroBox plc 25 January 2004 26 January 2004 Contact: Jeremy Porter, Seymour Pierce +44 207 107 8000 David Bick, Holborn +44 207 929 5599 Aerobox plc Share...
Innobox Plc (the "Company") Part disposal of investment in AeroBox Plc 23 January 2004 The Company announces that yesterday it sold 1,000,000 out of the 4,500,002 ordinary shares that it holds...
RNS Number:4546U AeroBox plc 21 January 2004 21 January 2004 Contact: David Bick, Holborn +44 207 929 5599 Aerobox plc Aerobox plc announces the first commercial sales of the...
RNS Number:3622R AeroBox plc 28 October 2003 28 October 2003 AeroBox plc ("AeroBox" or the "Company") Appointment of David Sebire as Chairman AeroBox plc is pleased to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.035 | -5.07246376812 | 0.69 | 0.695 | 0.625 | 346960 | 0.64741536 | DE |
4 | 0.035 | 5.64516129032 | 0.62 | 9.4 | 0.615 | 501658 | 0.67441998 | DE |
12 | 0.135 | 25.9615384615 | 0.52 | 9.4 | 0.5 | 300348 | 0.6315771 | DE |
26 | 0.035 | 5.64516129032 | 0.62 | 9.4 | 0.44 | 467418 | 0.56160618 | DE |
52 | -0.125 | -16.0256410256 | 0.78 | 9.4 | 0.44 | 419915 | 0.57166727 | DE |
156 | -0.395 | -37.619047619 | 1.05 | 9.4 | 0.44 | 308539 | 0.74658786 | DE |
260 | 0.49 | 296.96969697 | 0.165 | 9.4 | 0.165 | 365692 | 0.96679435 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions